Better understanding the tumor microenvironment starts with comprehensive gene expression profiling.

The NanoString nCounter® PanCancer IO 360™ Gene Expression Panel is designed to characterize immune responses within the tumor microenvironment, supporting biomarker discovery and immunotherapy research. This white paper presents qualification studies demonstrating the panel's analytical performance and reliability for laboratory-developed testing and exploratory oncology research.

Key topics include:

• Qualification of the NanoString nCounter PanCancer IO 360 Gene Expression Panel
• Evaluation of analytical performance, including RNA input, precision, and accuracy
• Characterization of 770 genes across 16 immuno-oncology pathways
• Applications for biomarker discovery, tumor microenvironment profiling, and immunotherapy research

The qualification studies demonstrated strong performance across multiple RNA input levels, with consistent precision and accuracy supporting the panel's use in exploratory cancer research. Learn how comprehensive gene expression profiling can help identify prognostic and predictive biomarkers while advancing precision oncology and immunotherapy development.